The Information and Knowledge Center of AMN published this morning (Sunday) a data report according to which 7,545 new verified patients were diagnosed yesterday, which is 5.39 percent of all tests - 139,907.
This is a decrease in the number of patients, which averaged 10,280 last week.
The number of serious patients stands at 721 patients and this is an increase of 39 patients compared to yesterday.
The encouraging news comes from the direction of the infection coefficient, which fell below 1 again, and stands at 0.91.
The number of active carriers is 85,739 and this is an average increase of about a thousand patients compared to last week when the number of active carriers was 84,233.
The coefficient of infection dropped to 0.91 // Photo: David Cohen-Ginny,
The report notes: “There is still a very significant potential of citizens, especially middle-aged people, who are entitled to be vaccinated in the third dose but have not yet exercised it and thus put themselves at unnecessary and completely preventable risks.
Therefore, those entitled to be vaccinated against the urge to urinate - including young people - are advised to do so without delay, given the rising morbidity in the country.
The more of us get vaccinated in the third dose, the sooner we can all get back to a safe routine.
"The data show that the third vaccine is effective and safe. The findings of a large study conducted in Israel show that the third vaccine increases up to ten times both those infected with infection and a serious illness, compared to those who are vaccinated with only two doses. "This widespread immunization has led to a halt in the rise in serious morbidity among vaccinated people."
The third vaccine for people aged 65 and over has been approved by the FDA,
Commenting on the FDA decision: "Committee members examined the research data (including from Israel) on vaccine attenuation over time and the increase in protection afforded after the third vaccine, and were convinced that the third dose was likely to increase corona virus protection in these groups. "B, and graded, as it was in Israel.
"The experts' recommendation was based on the latest disease data in the United States, just as the Ministry of Health operates according to the risk levels in Israel and not in the United States. It should be noted that other important countries (such as Britain, France, Spain, Germany, Ireland, Austria and Italy) "Third, similar to Israel, and did not wait for the FDA's decision on the matter."